Abstract: We have studied the influence of 2-(4'-nitrostyryl)-quinoline-1-oxide (2-NSQO) and 4-(4'-nitrostyryl)-quinoline-1-oxide (4-NSQO) on modulation activity of microsomal NADPH-oxidoreductases, concentration of nicotinamide enzymes and induction of apoptosis in human erythroleukaemic K562 cells. It was shown, that activity of microsomal NADPH-cytochrome c-reductases in cancer cells was inhibited by 10 μM 4-NSQO (15%), and 10 μM 2-NSQO (50%). Treatment of cells with these reagents for two days, was accompanied by caspases-9 and -3 activation, rise of EtBr and DAPI fluorescence related to DNA binding and induction of apoptosis. Apoptosis was preceded by the decrease of concentration of nicotinamide enzymes. Thus 4-NSQO is a promising compound for further experimental trials as an anticancer drug with low toxic action on the tissues of organism.
Reference: Volkova T.O., Zykina N.S., Malycheva I.E., Nemova N.N., Cell mechanisms underlying induction of apoptosis in human erythroleukaemic K562 cells line treated byquinoline-n-oxide derivatives, Biomeditsinskaya khimiya, 2006, vol:
1. Parodi M.T., Tonini G.P., Bologna R. et al. (1988) Boll. Ist. Sieroter. Milan, 67, 142-148.
2. Jeannesson P., Lahlil R., Chenais B. et al. (1997) Leuk. Lymphoma, 26, 575-587.
3. Garcia-Bermejo L., Vilaboa N.E., Perez C. et al. (1997) Exp. Cell Res., 236, 268-274.
4. Анисимов А.Г., Болотников И.А., Чекмасова А.А. и др. (2000) Цитология, 42, 10, 923-936.